RT Journal Article
SR Electronic
T1 Gastrokine 1 induces senescence through p16/Rb pathway activation in gastric cancer cells
JF Gut
JO Gut
FD BMJ Publishing Group Ltd and British Society of Gastroenterology
SP 43
OP 52
DO 10.1136/gut.2010.230623
VO 61
IS 1
A1 Xing, Rui
A1 Li, Wenmei
A1 Cui, Jiantao
A1 Zhang, Jun
A1 Kang, Bin
A1 Wang, Yuan
A1 Wang, Zhaohui
A1 Liu, Siqi
A1 Lu, Youyong
YR 2012
UL http://gut.bmj.com/content/61/1/43.abstract
AB Background and aims Gastrokine 1 (GKN1) is a stomach-specific protein that is normally expressed in gastric mucosa but not in primary tumours and cell lines. Based on this evidence, it was presumed that GKN1 might play a role in gastric cancer development; however, its function and molecular mechanism are not clear. A systematic study was initiated that combined multiple approaches to define the molecular mechanism of GKN1 in gastric cancer cells.Method Proteomics, western blotting and immunohistochemistry were used to measure the expression level of GKN1. Western blotting combined with immunofluorescence was used to monitor the secretory process of this protein. Subsequently, the function and molecular mechanism of GKN1 was explored in vitro and in vivo.Results It was shown that GKN1 is an autocrine/paracrine protein and inhibits cell growth due to senescence, which resulted from activation of p16/Rb and p21waf pathways. Furthermore, sustained activation of Ras/Raf/MEK/ERK signalling was characterised in gastric cancer cells and a xenograft nude mouse model following GKN1 treatment.Conclusion These results provide comprehensive molecular evidence of GKN1 in inducing senescence of gastric cancer cells, and indicate that GKN1 might be a potential novel target for gastric cancer therapeutics.